Painful diabetic neuropathy: A management-centered review

Clinical Diabetes

Volumn 25, Issue 1, 2007, Pages 6-15

  Huizinga, Mary Margaret ^a,b   Peltier, Amanda ^c  

^a Valley Health   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CYANOCOBALAMIN; DESIPRAMINE; DOXEPIN; DULOXETINE; FLUOXETINE; GABAPENTIN; GLIBENCLAMIDE; GLITAZONE DERIVATIVE; IMIPRAMINE; INSULIN; LAMOTRIGINE; METFORMIN; MEXILETINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PARACETAMOL; PAROXETINE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; AGITATION; AGRANULOCYTOSIS; ALOPECIA; ANALGESIA; ANOREXIA; APLASTIC ANEMIA; APPLICATION SITE BURNING; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ATAXIA; BICARBONATE BLOOD LEVEL; BLOOD PRESSURE; BLURRED VISION; BURNING SENSATION; CARDIOTOXICITY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; COUGHING; CYANOCOBALAMIN DEFICIENCY; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC PROCEDURE; DIARRHEA; DIPLOPIA; DISEASE CLASSIFICATION; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPEPSIA; EPIDEMIOLOGICAL DATA; FALLING; FATIGUE; FEMALE; GLYCEMIC CONTROL; HEADACHE; HEART ARRHYTHMIA; HEART PROARRHYTHMIA; HEART RATE; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERESTHESIA; HYPERTENSION; HYPERTHERMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; INSULIN TREATMENT; KIDNEY DYSFUNCTION; LEG PAIN; LEUKOPENIA; LIVER TOXICITY; LOW DRUG DOSE; MALE; MEMORY DISORDER; METABOLIC ACIDOSIS; MIGRAINE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NYSTAGMUS; OPIATE ADDICTION; ORTHOSTATIC HYPOTENSION; PANCREATITIS; PARESTHESIA; PATIENT COMPLIANCE; PATIENT MONITORING; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PR INTERVAL; PRESSURE SENSATION; PROPHYLAXIS; PRURITUS; PSYCHOMOTOR DISORDER; REVIEW; RHABDOMYOLYSIS; RHINITIS; RISK FACTOR; SECONDARY GLAUCOMA; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SNEEZING; SOMNOLENCE; SPEECH DISORDER; SWEATING; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; TREMOR; URINE RETENTION; VIBRATION SENSE; VOMITING; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 33846974022     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.25.1.6     Document Type: Review

References (82)

1. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ 3rd, Service FJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
2. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150-154, 1993
3. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's translation). Diabetes Metab 3:245-256, 1977
4. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, Ward JD, Boulton AJ: The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 11:480-484, 1994
5. Cabezas-Cerrato J: The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 41:1263-1269, 1998
6. Boulton AJ, Gries FA, Jervell JA: Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med 15:508-514, 1998
7. Backonja MM, Krause SJ: Neuropathic pain questionnaire: short form. Clin J Pain 19:315-316, 2003
8. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956-962, 2005
9. Vinik AI, Park TS, Stansberry KB, Pittenger GL: Diabetic neuropathies. Diabetologia 43:957-973, 2000
10. Aring AM, Jones DE, Falko JM: Evaluation and prevention of diabetic neuropathy. Am Fam Physician 71:2123-2128, 2005
11. Galer BS, Gianas A, Jensen MP: Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47:123-128, 2000
12. Vileikyte L, Peyrot M, Bundy C, Rubin RR, Leventhal H, Mora P, Shaw JE, Baker P, Boulton AJM: The development and validation of a neuropathy-and foot ulcer-specific quality of life instrument. Diabetes Care 26:2549-2555, 2003
13. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA: Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 61:160-173, 2004
14. Perkins BA, Olaleye D, Zinman B, Bril V: Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 24:250-256, 2001
15. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF: The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 18:216-219, 1995
16. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies. Diabetes Care 27:1458-1486, 2004
17. Dyck P: Severity and staging of diabetic polyneuropathy. In Textbook of Diabetic Neuropathy. Gries FA, Cameron NE, Low PA, Ziegler D, Eds. Stuttgart, Germany, Thieme Medical Publishers, 2003, p. 170-175
18. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:89-94, 1995
19. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG: Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20:1162-1167, 1997
20. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW: Assessment and management of foot disease in patients with diabetes. N Engl J Med 331:854-860, 1994
21. Writing Team for the DCCT/EDIC Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-2569, 2002
22. Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL: Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 29:340-344, 2006
23. Kamei J, Mizoguchi H, Narita M, Tseng LF: Therapeutic potential of PKC inhibitors in painful diabetic neuropathy. Expert Opin Investig Drugs 10:1653-1664, 2001
24. Rull JA, Quibrera R, Gonzalez-Millan H, Lozano Castaneda O: Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 5:215-218, 1969
25. Davis JL, Lewis SB, Gerich JE, Kaplan RA, Schultz TA, Wallin JD: Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. JAMA 238:2291-2292, 1977
26. Sindrup SH, Otto M, Finnerup NB, Jensen TS: Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96:399-409, 2005
27. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389-400, 1999
28. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA: A systematic review of antidepressants in neuropathic pain. Pain 68:217-227, 1996
29. McQuay HJ, Carroll D, Glynn CJ: Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 48:281-285, 1993
30. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH: Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:289-305, 2005
31. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589-596, 1987
32. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992
33. Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, Ward WK, Bernstein JE: A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 12:111-120, 1995
34. Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstrom T, Thorell LH: A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 13:313-323, 1997
35. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA: Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159:1931-1937, 1999
36. Kvinesdal B, Molin J, Froland A, Gram LF: Imipramine treatment of painful diabetic neuropathy. JAMA 251:1727-1730, 1984
37. Young RJ, Clarke BF: Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs. Diabet Med 2:363-366, 1985
38. Sindrup SH, Ejlertsen B, Froland A, Sindrup EH, Brosen K, Gram LF: Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 37:151-153, 1989
39. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42:135-144, 1990
40. Sindrup SH, Tuxen C, Gram LF, Grodum E, Skjold T, Brosen K, Beck-Nielsen H: Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol 43:251-255, 1992
41. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS: Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60:1284-1289, 2003
42. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H: Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms: a double-blind cross-over study. Br J Clin Pharmacol 30:683-691, 1990
43. Max MB, Kishore-Kumar R, Schafer SC, Meister B, Gracely RH, Smoller B, Dubner R: Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 45:3-9, 1991
44. Glassman AH, Roose SP, Bigger JT Jr: The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA 269:2673-2675, 1993
45. Fernstrom MH, Kupfer DJ: Antidepressant-induced weight gain: a comparison study of four medications. Psychiatry Res 26:265-271, 1988
46. Davis JL, Smith RL: Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care 22:1909-1910, 1999
47. Rowbotham MC, Goli V, Kunz NR, Lei D: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110:697-706, 2004
48. Corbett CF: Practical management of patients with painful diabetic neuropathy. Diabetes Educ 31:523-524, 526-528, 530 passim, 2005
49. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109-118, 2005
50. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF: The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 52:547-552, 1992
51. Gomez-Perez FJ, Choza R, Rios JM, Reza A, Huerta E, Aguilar CA, Rull JA: Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 27:525-529, 1996
52. Chakrabarti AK, Samantaray SK: Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. Aust N Z J Med 6:565-568, 1976
53. Wilton TD: Tegretol in the treatment of diabetic neuropathy. S Afr Med J 48:869-872, 1974
54. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A: Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 57:505-509, 2001
55. Eisenberg E, Alon N, Ishay A, Daoud D, Yarnitsky D: Lamotrigine in the treatment of painful diabetic neuropathy. Eur J Neurol 5:167-173, 1998
56. Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S: Sodium valproate in the management of painful neuropathy in type 2 diabetes: a randomized placebo controlled study. Acta Neurol Scand 106:248-252, 2002
57. Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, Garg P: Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 97:33-38, 2004
58. Otto M, Bach FW, Jensen TS, Sindrup SH: Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 62:285-288, 2004
59. Vanina Y, Podolskaya A, Sedky K, Shahab H, Siddiqui A, Munshi F, Lippmann S: Body weight changes associated with psychopharmacology. Psychiatr Serv 53:842-847, 2002
60. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI: Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63:865-873, 2004
61. Thienel U, Neto W, Schwabe SK, Vijapurkar U: Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 110:221-231, 2004
62. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831-1836, 1998
63. Simpson D: Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis 3:53-62, 2001
64. Gorson KC, Schott C, Herman R, Ropper AH, Rand WM: Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 66:251-252, 1999
65. DeToledo JC, Toledo C, DeCerce J, Ramsay RE: Changes in body weight with chronic, highdose gabapentin therapy. Ther Drug Monit 19:394-396, 1997
66. Lesser H, Sharma U, LaMoreaux L, Poole RM: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 63:2104-2110, 2004
67. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638, 2004
68. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6:253-260, 2005
69. Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E, Tarsy D: Does capsaicin relieve the pain of diabetic neuropathy? Pain 42:387-388, 1990
70. Scheffler NM, Sheitel PL, Lipton MN: Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 81:288-293, 1991
71. The Capsaicin Study Group: Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 151:2225-2229, 1991
72. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ: Topical capsaicin in painful diabetic neuropathy: controlled study with long-term follow-up. Diabetes Care 15:8-14, 1992
73. Low PA, Opfer-Gehrking TL, Dyck PJ, Litchy WJ, O'Brien PC: Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 62:163-168, 1995
74. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M: Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50:1842-1846, 1998
75. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS: Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 83:85-90, 1999
76. Oskarsson P, Ljunggren JG, Lins PE: Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care 20:1594-1597, 1997
77. Stracke H, Meyer UE, Schumacher HE, Federlin K: Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 15:1550-1555, 1992
78. Stracke H, Meyer U, Schumacher H, Armbrecht U, Beroniade S, Buch KD, Federlin K, Haupt E, Husstedt IW, Kampmann B: Mexiletine in treatment of painful diabetic neuropathy. Med Klin (Munich) 89:124-131, 1994
79. Dejgard A, Petersen P, Kastrup J: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1:9-11, 1988
80. Wright JM, Oki JC, Graves L 3rd: Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother 31:29-34, 1997
81. Turk DC, Rudy TE: Neglected topics in the treatment of chronic pain patients: relapse, noncompliance, and adherence enhancement. Pain 44:5-28, 1991
82. VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel: Duloxetine (Cymbalta) in painful diabetic neuropathy and fibromyalgia [article online]. Available from http://www.pbm.va.gov/monograph/ 6upaeDuloxetine.pdf